Eastman Chemical (NYSE:EMN - Free Report) - Zacks Research decreased their Q2 2025 EPS estimates for shares of Eastman Chemical in a report issued on Thursday, April 10th. Zacks Research analyst R. Department now expects that the basic materials company will post earnings of $2.19 per share for the quarter, down from their prior estimate of $2.20. The consensus estimate for Eastman Chemical's current full-year earnings is $8.55 per share. Zacks Research also issued estimates for Eastman Chemical's Q3 2025 earnings at $2.25 EPS, Q4 2025 earnings at $1.91 EPS, FY2025 earnings at $8.25 EPS, Q1 2026 earnings at $2.03 EPS, Q2 2026 earnings at $2.36 EPS, Q3 2026 earnings at $2.42 EPS, Q4 2026 earnings at $2.39 EPS, FY2026 earnings at $9.20 EPS, Q1 2027 earnings at $2.46 EPS and FY2027 earnings at $10.24 EPS.
Eastman Chemical (NYSE:EMN - Get Free Report) last issued its quarterly earnings results on Thursday, January 30th. The basic materials company reported $1.87 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.27. Eastman Chemical had a return on equity of 16.27% and a net margin of 9.65%.
Other equities research analysts also recently issued research reports about the stock. Barclays reduced their price target on shares of Eastman Chemical from $111.00 to $108.00 and set an "equal weight" rating for the company in a research report on Monday, February 3rd. JPMorgan Chase & Co. upped their target price on shares of Eastman Chemical from $110.00 to $112.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. UBS Group dropped their price target on shares of Eastman Chemical from $123.00 to $115.00 and set a "buy" rating for the company in a research report on Monday, April 7th. Mizuho upgraded shares of Eastman Chemical from a "neutral" rating to an "outperform" rating and set a $105.00 price objective on the stock in a research report on Thursday, April 3rd. Finally, Wells Fargo & Company decreased their target price on shares of Eastman Chemical from $125.00 to $90.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 9th. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $107.08.
Read Our Latest Stock Report on Eastman Chemical
Eastman Chemical Stock Down 1.5 %
Eastman Chemical stock traded down $1.20 during mid-day trading on Friday, reaching $76.48. The stock had a trading volume of 322,710 shares, compared to its average volume of 1,233,999. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.51 and a quick ratio of 0.78. The company has a market capitalization of $8.81 billion, a price-to-earnings ratio of 9.96, a PEG ratio of 1.22 and a beta of 1.38. Eastman Chemical has a one year low of $70.90 and a one year high of $114.50. The company has a 50-day moving average price of $91.09 and a two-hundred day moving average price of $96.76.
Eastman Chemical Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Monday, April 7th. Shareholders of record on Friday, March 14th were issued a $0.83 dividend. The ex-dividend date was Friday, March 14th. This represents a $3.32 dividend on an annualized basis and a dividend yield of 4.34%. Eastman Chemical's dividend payout ratio is currently 43.23%.
Institutional Trading of Eastman Chemical
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Raymond James Financial Inc. purchased a new position in Eastman Chemical during the 4th quarter worth approximately $150,537,000. Capital World Investors purchased a new stake in Eastman Chemical in the 4th quarter worth $137,848,000. Norges Bank acquired a new position in shares of Eastman Chemical during the 4th quarter worth about $137,416,000. Wealthfront Advisers LLC lifted its stake in Eastman Chemical by 3,136.8% in the 4th quarter. Wealthfront Advisers LLC now owns 736,011 shares of the basic materials company's stock valued at $67,213,000 after buying an additional 713,272 shares in the last quarter. Finally, Capital Research Global Investors boosted its holdings in Eastman Chemical by 13.4% in the 4th quarter. Capital Research Global Investors now owns 5,886,564 shares of the basic materials company's stock worth $537,561,000 after buying an additional 697,388 shares during the last quarter. Institutional investors and hedge funds own 83.65% of the company's stock.
About Eastman Chemical
(
Get Free Report)
Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.
Recommended Stories
Before you consider Eastman Chemical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eastman Chemical wasn't on the list.
While Eastman Chemical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
